
Merit Medical Systems MMSI
$ 86.89
-1.42%
Quarterly report 2025-Q2
added 07-30-2025
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
58.2 M |
Market Cap[1] |
$ 5.06 B |
EBITDA (LTM) |
$ 272 M |
P/E (LTM) |
40.81 |
P/S (LTM) |
3.62 |
EPS (LTM) |
2.16 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Baxter International
BAX
|
$ 19.51 | 2.09 % | $ 9.95 B | NYSE,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 194.82 | 0.39 % | $ 56 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 7.87 | -8.91 % | $ 159 M | Nasdaq Capital Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Harvard Bioscience
HBIO
|
$ 0.66 | -1.73 % | $ 28 M | Nasdaq Global Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Repro Med Systems
KRMD
|
$ 5.64 | -3.01 % | $ 257 M | Nasdaq Capital Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Alcon
ALC
|
$ 77.56 | -1.59 % | $ 40.4 B | NYSE | ||
|
Nephros
NEPH
|
$ 4.88 | -0.03 % | $ 50.7 M | Nasdaq Global Select Market | ||
|
AtriCure
ATRC
|
$ 39.21 | -0.88 % | $ 1.84 B | Nasdaq Global Market,SPB | ||
|
ICU Medical
ICUI
|
$ 140.89 | -1.25 % | $ 3.44 B | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 4.48 | -0.11 % | $ 24.7 K | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 176.72 | -0.41 % | $ 5.51 B | Nasdaq Global Select Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 12.68 | -1.25 % | $ 518 M | Nasdaq Global Select Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
The Cooper Companies
COO
|
$ 81.36 | -0.74 % | $ 16.2 B | NYSE,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 111.38 | -1.36 % | $ 5.39 B | NYSE,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 80.92 | -0.22 % | $ 1.82 B | Nasdaq Global Market,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 79.59 | -0.7 % | $ 4.01 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 8.71 | -2.9 % | $ 180 M | NYSE American | ||
|
Masimo Corporation
MASI
|
$ 127.32 | -2.11 % | $ 6.79 B | Nasdaq Global Select Market,SPB | ||
|
STERIS plc
STE
|
$ 250.01 | -1.38 % | $ 24.6 B | NYSE,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 559.18 | -1.27 % | $ 199 B | Nasdaq Global Select Market,SPB | ||
|
OraSure Technologies
OSUR
|
$ 2.44 | 1.03 % | $ 182 M | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.07 | 3.6 % | $ 21.1 M | Nasdaq Global Select Market | ||
|
Utah Medical Products
UTMD
|
$ 56.55 | 1.06 % | $ 205 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | 5.05 % | $ 23.1 M | NYSE American | ||
|
Stereotaxis
STXS
|
$ 2.31 | 0.43 % | $ 186 M | NYSE American | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 21.71 | - | $ 3.74 B | NYSE | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.37 | -0.56 % | $ 2.31 B | Nasdaq Global Select Market,SPB | ||
|
Pro-Dex
PDEX
|
$ 38.52 | 0.1 % | $ 127 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 32.4 M | Nasdaq Capital Market | ||
|
Pulse Biosciences
PLSE
|
$ 13.42 | -2.26 % | $ 645 M | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 243.75 | 1.2 % | $ 35.6 B | NYSE,SPB | ||
|
Repligen Corporation
RGEN
|
$ 164.81 | 0.58 % | $ 9.18 M | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 24.22 | 0.14 % | $ 1.12 B | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.77 | -0.7 % | $ 23.1 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 23.57 | 2.08 % | $ 1.16 B | Nasdaq Global Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 121.96 | -0.1 % | $ 5.71 B | NYSE,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 275.24 | - | $ 20.1 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.